4:00 PM - 5:30 PM Friday, January 15

Plenary Session I

Plenary I will showcase the top-scoring late-breaking abstracts. Each late-breaking abstract presentation is followed by a live-stream Q&A with the moderator and the abstract's presenting author. This plenary session will conclude with the Presential Address and award aknowledgements.

5:45 PM - 6:45 PM Friday, January 15

Plenary Session II

Advances in the field of neuromodulation are increasingly dependent on integrating advanced technologies. During this session, we will explore two exceptional examples, including the advanced integration of robotics and neuromodulation for stroke rehabilitation and using advanced intracranial mapping and analytic techniques to understand how both depression and deep brain stimulation affect brain activity. This session will also highlight a major innovation in restoring movement in spinal cord injury.

9:00 AM - 10:35 AM Saturday, January 16

Plenary Session III

During this session, we will explore the new hope for extending the indications for neuromodulation to new frontiers. In many cases, these breakthrough areas in neuromodulation are being funded by large investments by the NIH and other agencies. Key opinion leaders will review innovative new research and clinical trials being conducted in gastric, respiratory, and cardiac function.  Also, investigating neuromodulation for off-label and orphan indications will be critically reviewed.

8:00 AM - 10:00 AM Friday, January 24

Plenary Session I -- What We Have Learned About Placebo: Implications for Clinical Practice and the Interpretation of Evidence About Analgesics

The placebo effect is a known aspect in the practice of medicine. In the clinical setting, it has been relegated to statistical confounds. In this session, we will discuss ways to identify and predict the placebo effect as well as brain connectivity that leads to placebo.

Caesars Palace

Ricardo Vallejo, MD PhD

Nathaniel P. Katz, MD MS

Subscribe to this RSS feed

Faculty subject to change.